Valuation Ind-Swift Laboratories Limited

Stocks

Market Closed - NSE India S.E. 12:05:08 12/08/2026 BST			5-day change	1st Jan Change
300.00 ^INR	+5.38%		+30.32%	+240.33%

08-10	Ind-Swift Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
07-09	Ind-Swift Laboratories Limited announced that it expects to receive INR 343 million in funding	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	1,202	4,251	3,938	3,262	5,918	4,961
Change	-	253.56%	-7.37%	-17.18%	81.43%	-16.17%
Enterprise Value (EV) ¹	11,410	14,189	13,254	11,701	1,764	695.5
Change	-	24.36%	-6.59%	-11.72%	-84.92%	-60.59%
P/E	-4.75x	-135x	-183x	6.85x	1.41x	2.38x
PBR	0.19x	0.7x	0.66x	0.48x	0.64x	0.49x
PEG	-	1.5x	5.8x	-0x	0x	-0x
Capitalization / Revenue	0.15x	0.47x	0.37x	0.27x	0.46x	0.88x
EV / Revenue	1.43x	1.56x	1.26x	0.96x	0.14x	0.12x
EV / EBITDA	8.88x	8.54x	5.96x	4.9x	0.66x	-3.19x
EV / EBIT	15.4x	12.8x	14.3x	6.45x	0.82x	-1.59x
EV / FCF	46.6x	58x	49.3x	26.6x	0.18x	-0.33x
FCF Yield	2.15%	1.72%	2.03%	3.76%	558%	-302%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-4.284	-0.5326	-0.3637	8.055	71.24	35.21
Distribution rate	-	-	-	-	-	-
Net sales ¹	7,993	9,068	10,521	12,159	12,973	5,617
EBITDA ¹	1,285	1,661	2,224	2,389	2,683	-217.8
EBIT ¹	739.6	1,110	924.1	1,815	2,150	-438.6
Net income ¹	-211.9	-31.47	-21.49	476	4,210	2,505
Net Debt ¹	10,207	9,938	9,315	8,439	-4,153	-4,265
Reference price ²	20.35	71.95	66.65	55.20	100.15	83.96
Nbr of stocks (in thousands)	59,087	59,087	59,087	59,087	59,087	59,087
Announcement Date	07/09/20	07/09/21	07/09/22	05/09/23	06/09/24	05/09/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IND-SWIFT LABORATORIES LIMITED	-	-	-	-	260M
SUN PHARMACEUTICAL INDUSTRIES LTD.	35.83x	6.73x	23.32x	0.88%	48.85B
OTSUKA HOLDINGS CO., LTD.	19.79x	2.33x	10.61x	1.31%	41.43B
ZYDUS LIFESCIENCES LIMITED	29.78x	4.1x	16.66x	0.56%	12.46B
CIPLA LIMITED	28.48x	3.47x	17.99x	0.89%	12.39B
KRKA, D. D.	18.73x	3.33x	11.58x	3.85%	9.08B
GEDEON RICHTER	9.14x	2.11x	5.5x	4.4%	7.53B
ONO PHARMACEUTICAL CO., LTD.	15.92x	2.06x	6.44x	3.24%	7.14B
GLENMARK PHARMACEUTICALS LIMITED	34.55x	3.94x	16.76x	0.23%	6.73B
Average	24.03x	3.51x	13.61x	1.92%	16.21B
Weighted average by Cap.	26.64x	4.17x	15.89x	1.43%